Advanced medical care

Information regarding advanced medical care

1. What is advanced medical care?

An advanced medical care system coordinates advanced medical techniques and general health insurance treatment in response to new medical technologies and the diversified needs of medical care. When approved, costs for some procedures  carried out during advanced medical care treatment (usually borne by the individual and not covered under insurance) are classified as regular medical treatment (usually covered by insurance) in order to reduce the burden to the patient. 
Asahikawa Medical University Hospital is an approved advanced medical care hospital with a highly skilled medical staff and well-equipped facilities, both in terms of quality and quantity.

2. What kind of advanced medical care is available?

As of January 2023, 86 types of advanced medical care have been approved by The Ministry of Health, Labor and Welfare. The following advanced medical care is available at Asahikawa Medical University Hospital.

Name of the advanced medical care Date of approval Amount Department Treated
Rapid diagnosis for ocular infectious diseases using Polymerase Chain Reaction (PCR method) September, 1, 2020 29,700 yen Ophthalmology
Physiological, hyaluronan-selected intracytoplasmic sperm injection April 1, 2022 43,230 yen Obstetrics & Gynecology
Endometrial Receptivity Analysis 1 April 1, 2022 93,830 yen Obstetrics & Gynecology
Endometrial Microbiome Metagenomic Analysis 2  November 1, 2022 35,750 yen Obstetrics & Gynecology

 

3. Applicable diseases

Rapid diagnosis for ocular infectious dieseases using Polymerase Chain Reaction (PCR method)

Anterior ocular disease with mutton-fat keratic precipitate or elevated intraocular pressure symptoms affecting one eye.
(limited to suspected herpetic corneal endotheliitis or herpetic iritis)
Fundus disease with retinal necrotic foci
(limited to suspected acute retinal necrosis, cytomegalovirus retinitis, or progressive outer retinal necrosis)

Physiological, hyaluronan-selected intracytoplasmic sperm injection

For patients who receive an embryo transfer (limited to patients with repeated miscarriage after embryo transfer or with abnormal spermatozoon)

Endometrial Receptivity Analysis 1

For patients who receive an embryo transfer (limited to patients with repeated failure to achieve implantation or pregnancy)

Endometrial Microbiome Metagenomic Analysis 2

Infertility (limited to patients with repeated failure to achieve implantation or pregnancy), Suspected chronic endometritis or refractory bacterial vaginosis